We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
HeartBeam Upgraded to Buy as FDA-Cleared ECG System Nears Market
about 1 hour ago

Catalyst Crew Rebrands as LataMed AI in Major Healthcare Tech Pivot
about 2 hours ago

AHA and Laerdal Launch Self-Guided CPR Training Nationwide
about 4 hours ago

OpticWise: CRE Owners Must Reclaim Tech Strategy from Vendors
about 5 hours ago

BAC Launches Grassroots Fundraising Drive After Privacy Act Victory
about 5 hours ago

HR News
HR.com Announces 2026 Leadership Development Award Winners
about 7 hours ago
Global Hiring Accelerates Amid AI Reshaping and Engagement Strain in 2026
about 12 hours ago
Fractional HR: Texas's Answer to Growth & Compliance Risks
7 days ago
HR.com Honors Top CHROs and Women Leaders in 2026 Awards
7 days ago
Galaxy Payroll Renews 5-Year Strategic Deal with Nike Macau
8 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
HeartBeam Upgraded to Buy as FDA-Cleared ECG System Nears Market
about 1 hour ago
Uniserve Advances Vancouver Data Centre, Targets Canadian SMB Digital Infrastructure Leadership
about 2 hours ago
Crypto News
NxGen Launches $CAND Token on Solana, Merging Candy Brands with Blockchain Rewards
1 day ago
Greenlane Unveils Berachain Crypto Strategy in New Investor Overview
1 day ago
Greenlane Deploys 50M BERA Tokens, Appoints New CEO for Crypto Treasury Push
1 day ago
BLAQclouds Launches ApolloNFT & theAlley V2 to Revolutionize Creator Economy
2 days ago
Datavault AI Announces Josh Gibson Coin Dividend for Shareholders
5 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
HeartBeam Upgraded to Buy as FDA-Cleared ECG System Nears Market
about 1 hour ago
Catalyst Crew Rebrands as LataMed AI in Major Healthcare Tech Pivot
about 2 hours ago
Technology News
GridAI Partners with Amp Z to Power Massive AI Data Center Expansion
27 minutes ago
JCB & Resona Launch World's First Project to Commercialize Hands-Free UWB Payments
32 minutes ago
Uniserve Advances Vancouver Data Centre, Targets Canadian SMB Digital Infrastructure Leadership
about 2 hours ago
Invech Holdings Acquires Paragon Rentals AI, Enters Real Estate Tech Market
about 4 hours ago
AHA and Laerdal Launch Self-Guided CPR Training Nationwide
about 4 hours ago
Events & Conferences
GBH Host Edgar B. Herwick III to Present 58th Annual Bell Ringer Awards
about 6 hours ago
Four Impact Companies Pitch Live on TV with Audience Q&A and Voting
about 12 hours ago
Human Rights Leaders Unite in DC to Build Practical Solutions for Dignity
about 12 hours ago
LA Launches Major Anti-Poverty Initiative with New Office and Department Consolidation
1 day ago
Texas Custom Turf Unveils Flexible Synthetic Grass Rugs for Central Texas
1 day ago






